Standout Papers

Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conj... 2007 2026 2013 2019 1.2k
  1. Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate (2008)
    Gail D. Lewis Phillips, Guangmin Li et al. Cancer Research
  2. Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy (2014)
    Ravi Chari, Michael L. Miller et al. Angewandte Chemie International Edition
  3. Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs (2007)
    Ravi Chari Accounts of Chemical Research
  4. Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer (2014)
    John M. Lambert, Ravi Chari Journal of Medicinal Chemistry

Immediate Impact

15 by Nobel laureates 11 from Science/Nature 102 standout
Sub-graph 1 of 19

Citing Papers

Cancer therapy with antibodies
2024 Standout
Engineering protein-based therapeutics through structural and chemical design
2023 Standout
26 intermediate papers

Works of Ravi Chari being referenced

Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy
2014 Standout
Disulfide-Linked Antibody−Maytansinoid Conjugates: Optimization of In Vivo Activity by Varying the Steric Hindrance at Carbon Atoms Adjacent to the Disulfide Linkage
2011
and 15 more

Author Peers

Author Last Decade Papers Cites
Ravi Chari 3604 3377 2565 76 6.2k
Damon L. Meyer 2867 2930 1737 40 4.8k
John M. Lambert 3924 3803 3336 127 8.0k
Victor S. Goldmacher 2410 2081 2734 90 6.5k
Alan F. Wahl 3218 1937 3074 64 6.8k
Walter A. Blättler 2304 2185 2032 37 4.4k
Tony Lahoutte 2066 4473 3076 158 7.1k
Roland Haubner 1986 3751 2693 91 7.2k
Caroline J. Springer 3115 871 6552 126 8.8k
Pamela A. Trail 1458 1187 1708 61 3.6k
Gary L. Griffiths 971 2232 1346 113 4.5k

All Works

Loading papers...

Rankless by CCL
2026